Thursday - December 18, 2025

AI Defense Stock VisionWave Holdings (Nasdaq: VWAV) Reports Completion of its Acquisition of Solar Drone Ltd.

AI Defense Stock VisionWave Holdings (Nasdaq: VWAV) Reports Completion of its Acquisition of Solar Drone Ltd. Acquisition of Solar Drone strengthens VisionWave’s autonomous mission systems and energy-infrastructure automation capabilities, adding a field-proven robotic platform for persistent, large-area operations with minimal … Continue reading

Peanut Allergy Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals | Stallergenes Greer, Roche and Novartis, DBV Technologies, Novartis, ALK-Abello, Aravax, InnoUp Farma

The Key Peanut Allergy Companies in the market include – Stallergenes Greer, Roche and Novartis, DBV Technologies, Novartis, ALK-Abello, Aravax, InnoUp Farma, Intrommune Therapeutics, and others. DelveInsight’s “Peanut Allergy Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding … Continue reading

IgA Nephropathy Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight | Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences, Shanghai Alebund Pharma

The Key IgA Nephropathy Companies in the market include – Travere Therapeutics, Asahi Kasei (Calliditas Therapeutics), Vertex Pharmaceuticals, Vera Therapeutics, Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences, Shanghai Alebund Pharmaceuticals, Rohto Pharmaceutical, Wuhan Createrna Science and Technology, Guangdong Hengrui … Continue reading

Hypercholesterolemia Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Hypercholesterolemia Pipeline Insight, 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Hypercholesterolemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product … Continue reading

Chronic Periodontitis Clinical Trial Pipeline Gains Momentum: 10+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Chronic Periodontitis Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Chronic Periodontitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment … Continue reading